Drug discontinuation: Everolimus Tablet
FDA lists 15 presentations as To Be Discontinued. Companies: Endo Pharmaceuticals, Inc., Par Health, USA LLC, Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., a Viatris Company.
- Published by source
- 2025-11-03
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Endo Pharmaceuticals, Inc.
- Products
- Everolimus Tablet
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacture of the drug
- A business decision was made to withdraw from sale.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2025-11-03
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #870 | new | 2026-10-22 | 02bd06bc3402…5f88fe | 364ded900081…cb169a |
Chain head: #1076 8ad5adc30b9b…88ce20